49 results on '"Mohs, Antje"'
Search Results
2. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling
3. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
4. Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
5. Functional role of CCL5/RANTES for HCC progression during chronic liver disease
6. NLRP3 and IL-1, but not IL-18, are drivers of hepatocellular carcinoma in two independent murine models
7. Cholestatic liver disease is alleviated by colitis-induced inhibition of bile acid synthesis
8. The cell cycle protein Cyclin E1 mediates pro-inflammatory signals in a mouse model of acute hepatitis and in primary macrophages
9. Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury
10. Colitis protects from primary sclerosing cholangitis via bile acid synthesis suppression
11. Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
12. Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
13. ACSL4-dependent ferroptosis promotes HCC progression
14. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis
15. ACSL4-dependent ferroptosis is not a major tumor-suppressive mechanism during HCC initiation and progression
16. NRF2/KEAP1 in hepatocytes controls fibro- and carcinogenesis in chronic liver disease
17. Blockage of CCL5/RANTES modifies immune infiltration and the inflammatory milieu during chronic liver disease: 65
18. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis
19. SAT-227 - NLRP3 and IL-1, but not IL-18, are drivers of hepatocellular carcinoma in two independent murine models
20. FRI-348 - The cell cycle protein Cyclin E1 mediates pro-inflammatory signals in a mouse model of acute hepatitis and in primary macrophages
21. FRI-334 - Cholestatic liver disease is alleviated by colitis-induced inhibition of bile acid synthesis
22. Disturbed gut microbiota and bile homeostasis in Giardia-infected mice contributes to metabolic dysregulation and growth impairment
23. Myeloid cells require IL-6/gp130 signaling for protective anti-inflammatory functions during bacterial peritonitis: 1951
24. Disturbed gut microbiota and bile homeostasis in Giardia -infected mice contributes to metabolic dysregulation and growth impairment
25. Gut microbiota drives hepatocarcinogenesis by promoting TLR4-dependent expansion of monocytic myeloid-derived suppressor cells
26. Gut microbiota maintains FXR activation and protects from fatal liver damage in a murine model of primary sclerosing cholangitis
27. The role of ferroptosis in chronic liver disease
28. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis
29. THU-479-The hepatocyte specific role of the NRF2/KEAP1 axis for HCC Progression during chronic liver disease
30. PS-159-Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2−/− mouse model of primary sclerosing cholangitis
31. SAT-379-Myeloid cells require gp130 signalling for protective antiinflammatory functions during sepsis
32. PS-042-Interventional targeting of cyclin E1 during hepatocarcinogenesis limits stem cell traits and hepatic myeloid cell homing and attenuates cancer progression
33. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
34. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis
35. Myeloid cells require gp130 signaling for protective anti‐inflammatory functions during sepsis
36. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
37. Functional role of CCL5/RANTES for HCC progression during chronic liver disease
38. Functional role of CCL5/RANTES for HCC progression during chronic liver disease
39. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
40. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease
41. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease
42. miR-155 targets Caspase-3 mRNA in activated macrophages
43. Hepatic overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response in a murine model of chronic liver disease.
44. miR-155 targets Caspase-3 mRNA in activated macrophages.
45. The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB–Stimulated Gene Transcription
46. GS04 - Gut microbiota drives hepatocarcinogenesis by promoting TLR4-dependent expansion of monocytic myeloid-derived suppressor cells.
47. AS127 - The role of ferroptosis in chronic liver disease.
48. AS113 - Gut microbiota maintains FXR activation and protects from fatal liver damage in a murine model of primary sclerosing cholangitis.
49. Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.